These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34581751)

  • 21. Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: Results from an exit survey of a phase 3, open-label, repeat-dose safety study.
    Penovich P; Wheless JW; Hogan RE; Guerra C; Cook DF; Carrazana E; Rabinowicz AL
    Epilepsy Behav; 2021 Aug; 121(Pt A):108013. PubMed ID: 34022621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance.
    Kasper S; Cubała WJ; Fagiolini A; Ramos-Quiroga JA; Souery D; Young AH
    World J Biol Psychiatry; 2021 Jul; 22(6):468-482. PubMed ID: 33138665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of liposomal nasal spray with vitamins A and E on allergic rhinitis.
    Lauriello M; di Marco GP; Necozione S; Tucci C; Pasqua M; Rizzo G; Eibenstein A
    Acta Otorhinolaryngol Ital; 2020 Jun; 40(3):217-223. PubMed ID: 32773784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro assessment of an idealized nose for nasal spray testing: Comparison with regional deposition in realistic nasal replicas.
    Chen JZ; Kiaee M; Martin AR; Finlay WH
    Int J Pharm; 2020 May; 582():119341. PubMed ID: 32305365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB
    JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anesthetic Efficacy of Intranasal 3% Tetracaine plus 0.05% Oxymetazoline (Kovanaze) in Maxillary Teeth.
    Capetillo J; Drum M; Reader A; Fowler S; Nusstein J; Beck M
    J Endod; 2019 Mar; 45(3):257-262. PubMed ID: 30803532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Simplified Geometric Model to Predict Nasal Spray Deposition in Children and Adults.
    Foo MY; Sawant N; Overholtzer E; Donovan MD
    AAPS PharmSciTech; 2018 Oct; 19(7):2767-2777. PubMed ID: 29948982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis.
    Williams AJ; Jordan F; King G; Lewis AL; Illum L; Masud T; Perkins AC; Pearson RG
    Int J Pharm; 2018 Jan; 535(1-2):113-119. PubMed ID: 29038066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nasal drug delivery device and its orientation on sprayed particle deposition in a realistic human nasal cavity.
    Tong X; Dong J; Shang Y; Inthavong K; Tu J
    Comput Biol Med; 2016 Oct; 77():40-8. PubMed ID: 27509293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
    Winner P; Farkas V; Štillová H; Woodruff B; Liss C; Lillieborg S; Raines S;
    Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect size comparison of ketorolac nasal spray and commonly prescribed oral combination opioids for pain relief after third molar extraction surgery.
    Niebler G; Dayno J
    Postgrad Med; 2016 Jan; 128(1):12-7. PubMed ID: 26616001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant corticosteroid nasal spray plus antihistamine (oral or local spray) for the symptomatic management of allergic rhinitis.
    Feng S; Fan Y; Liang Z; Ma R; Cao W
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3477-3486. PubMed ID: 26545381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurements of droplet size distribution and analysis of nasal spray atomization from different actuation pressure.
    Inthavong K; Fung MC; Yang W; Tu J
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):59-67. PubMed ID: 24914675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated actuation of nasal spray products: effect of hand-related variability on the in vitro performance of Flonase nasal spray.
    Doughty DV; Hsu W; Dalby RN
    Drug Dev Ind Pharm; 2014 Jun; 40(6):711-8. PubMed ID: 23594299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, prospective, double-blind study of the efficacy of dexpanthenol nasal spray on the postoperative treatment of patients with chronic rhinosinusitis after endoscopic sinus surgery.
    Tantilipikorn P; Tunsuriyawong P; Jareoncharsri P; Bedavanija A; Assanasen P; Bunnag C; Metheetrairut C
    J Med Assoc Thai; 2012 Jan; 95(1):58-63. PubMed ID: 22379743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump.
    Djupesland PG; Skretting A
    J Aerosol Med Pulm Drug Deliv; 2012 Oct; 25(5):280-9. PubMed ID: 22251061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis.
    Bernstein JA; Prenner B; Ferguson BJ; Portnoy J; Wheeler WJ; Sacks HJ
    Am J Rhinol Allergy; 2009; 23(5):512-7. PubMed ID: 19807985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the influence factors on in vitro testing of nasal sprays using Box-Behnken experimental design.
    Guo C; Stine KJ; Kauffman JF; Doub WH
    Eur J Pharm Sci; 2008 Dec; 35(5):417-26. PubMed ID: 18832029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.